After a nay from NICE, Scotland says aye to J&J’s SpravatoNHS patients with treatment-resistant depression in Scotland will be able to access Johnson & Johnson’s Spravato, a drug Share XAfter a nay from NICE, Scotland says aye to J&J’s Spravatohttps://pharmaphorum.com/news/after-a-nay-from-nice-scotland-says-aye-to-jjs-spravato/
Sanofi’s rare disease drug Cablivi approved in the EUThe European Commission has approved Sanofi’s Cablivi, the first treatment for patients with the rare blood-clotting disorder, acquired Share XSanofi’s rare disease drug Cablivi approved in the EUhttps://pharmaphorum.com/news/sanofi-cablivi-approved-europe/
